• Latest Posts
Interview 22 Jul 2019

Turning Shelved Drugs into a New Promise for Immuno-Oncology

BioNTech Raises Whopping €290M to Fund Personalized mRNA Vaccines for Cancer

Belgian Biotech’s €35M Series B to Fund Potential Type 1 Diabetes Cure

In Depth 11 Jun 2019

Gamma Delta T Cells: A New Hope Against Cancer

Highlights from European Biotech at ASCO 2019

ADVERTISEMENT

UK Immune Cell Therapy Biotech Founded with €40M Series A

‘Guided Missile’ Cancer Immunotherapy Boosted by €62M Funding

UK Government’s Bid on Healthcare Genomics Already Benefiting Biotechs

Czech Cell Therapy Increases Survival in Ovarian Cancer by 62%

Shares Drop 40% as Allergy Therapeutics Announces Failed Phase III Trial

ADVERTISEMENT